Laura Bergantini

5.4k total citations
131 papers, 2.0k citations indexed

About

Laura Bergantini is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Laura Bergantini has authored 131 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Pulmonary and Respiratory Medicine, 67 papers in Physiology and 23 papers in Immunology. Recurrent topics in Laura Bergantini's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (79 papers), Sarcoidosis and Beryllium Toxicity Research (45 papers) and Asthma and respiratory diseases (20 papers). Laura Bergantini is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (79 papers), Sarcoidosis and Beryllium Toxicity Research (45 papers) and Asthma and respiratory diseases (20 papers). Laura Bergantini collaborates with scholars based in Italy, Germany and United Kingdom. Laura Bergantini's co-authors include Elena Bargagli, Paolo Cameli, Miriana d’Alessandro, Piersante Sestini, Rosa Metella Refini, Paola Rottoli, Claudia Landi, Maria Pieroni, Lucia Vietri and Maria Antonietta Mazzei and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Laura Bergantini

122 papers receiving 2.0k citations

Peers

Laura Bergantini
Laura Bergantini
Citations per year, relative to Laura Bergantini Laura Bergantini (= 1×) peers Paolo Cameli

Countries citing papers authored by Laura Bergantini

Since Specialization
Citations

This map shows the geographic impact of Laura Bergantini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Bergantini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Bergantini more than expected).

Fields of papers citing papers by Laura Bergantini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Bergantini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Bergantini. The network helps show where Laura Bergantini may publish in the future.

Co-authorship network of co-authors of Laura Bergantini

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Bergantini. A scholar is included among the top collaborators of Laura Bergantini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Bergantini. Laura Bergantini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
d’Alessandro, Miriana, Edoardo Conticini, Laura Bergantini, et al.. (2024). Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of interstitial lung disease. Tissue and Cell. 90. 102516–102516.
2.
Soccio, Piera, Miriana d’Alessandro, Giulia Scioscia, et al.. (2024). Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis. Biomedicines. 12(2). 269–269. 5 indexed citations
3.
Bergantini, Laura, et al.. (2024). SARS-CoV-2 and Dysphagia: A Retrospective Analysis of COVID-19 Patients with Swallowing Disorders. Dysphagia. 40(1). 162–168.
4.
Bergantini, Laura, et al.. (2024). Immunological Similarities and Differences between Post-COVID-19 Lung Sequelae and Idiopathic Pulmonary Fibrosis. Biomedicines. 12(3). 630–630. 4 indexed citations
5.
Bergantini, Laura, Miriana d’Alessandro, Genny Del Zotto, Emanuela Marcenaro, & Elena Bargagli. (2023). Characterization of natural killer and T cells in bronchoalveolar lavage and peripheral blood of sarcoidosis patients. Frontiers in Immunology. 13. 1080556–1080556. 6 indexed citations
6.
Bergantini, Laura, et al.. (2023). Predictive Role of Cytokine and Adipokine Panel in Hospitalized COVID-19 Patients: Evaluation of Disease Severity, Survival and Lung Sequelae. International Journal of Molecular Sciences. 24(16). 12994–12994. 8 indexed citations
7.
d’Alessandro, Miriana, Piera Soccio, Elisabet Cantó, et al.. (2023). The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study. International Journal of Molecular Sciences. 24(4). 4071–4071. 5 indexed citations
8.
Bergantini, Laura, James Baker, Apostolos Bossios, et al.. (2023). ERS International Congress 2023: highlights from the Airway Diseases Assembly. ERJ Open Research. 10(2). 891–2023.
9.
Bergantini, Laura, et al.. (2022). Combined Sarcoidosis and Idiopathic Pulmonary Fibrosis (CSIPF): A New Phenotype or a Fortuitous Overlap? Scoping Review and Case Series. Journal of Clinical Medicine. 11(7). 2065–2065. 9 indexed citations
10.
Bergantini, Laura, Miriana d’Alessandro, Antonella Fossi, et al.. (2022). Characterization of NKG2-A/-C, Kir and CD57 on NK Cells Stimulated with pp65 and IE-1 Antigens in Patients Awaiting Lung Transplant. Life. 12(7). 1081–1081. 6 indexed citations
11.
Bergantini, Laura, Miriana d’Alessandro, Giuseppe Campiani, et al.. (2022). Bronchoalveolar-Lavage-Derived Fibroblast Cell Line (B-LSDM7) as a New Protocol for Investigating the Mechanisms of Idiopathic Pulmonary Fibrosis. Cells. 11(9). 1441–1441. 3 indexed citations
12.
d’Alessandro, Miriana, Laura Bergantini, Paolo Cameli, et al.. (2022). Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II. International Journal of Environmental Research and Public Health. 19(4). 2176–2176. 6 indexed citations
13.
d’Alessandro, Miriana, Laura Bergantini, Paolo Cameli, et al.. (2021). Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy. Cancers. 13(4). 689–689. 39 indexed citations
14.
Melani, Andrea S., et al.. (2021). A Comprehensive Review of Sarcoidosis Treatment for Pulmonologists. Pulmonary Therapy. 7(2). 325–344. 15 indexed citations
15.
Bergantini, Laura, et al.. (2021). NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19. Cells. 10(11). 3182–3182. 23 indexed citations
16.
d’Alessandro, Miriana, Piera Soccio, Laura Bergantini, et al.. (2021). Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach. Cells. 10(5). 1045–1045. 21 indexed citations
17.
Cameli, Paolo, Maria Concetta Pastore, Giulia Elena Mandoli, et al.. (2021). Strain Echocardiography Is a Promising Tool for the Prognostic Assessment of Sarcoidosis. Life. 11(10). 1065–1065. 3 indexed citations
18.
Bergantini, Laura, Elena Bargagli, Miriana d’Alessandro, et al.. (2021). Prognostic bioindicators in severe COVID-19 patients. Cytokine. 141. 155455–155455. 35 indexed citations
19.
Sartorelli, Pietro, Francesco Bianchi, Miriana d’Alessandro, et al.. (2020). Cytological analysis of bronchoalveolar lavage fluid in asbestos-exposed workers. ˜La œMedicina del lavoro. 111(5). 379–387. 7 indexed citations
20.
Bennett, David, Paolo Cameli, Nicola Lanzarone, et al.. (2020). Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis. Respiratory Research. 21(1). 6–6. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026